MULTIVOXEL PROTON MAGNETIC RESONANCE SPECTROSCOPY IN FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

被引:5
|
作者
Leung, Doris G. [1 ,2 ]
Wang, Xin [3 ]
Barker, Peter B. [4 ]
Carrino, John A. [5 ]
Wagner, Kathryn R. [1 ,2 ,6 ]
机构
[1] Kennedy Krieger Inst, Hugo W Moser Res Inst, Ctr Genet Muscle Disorders, 716 North Broadway,Room 411, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA
[3] Univ Nebraska Med Ctr, Dept Radiat Oncol, Omaha, NE USA
[4] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD USA
[5] Hosp Special Surg, Dept Radiol & Imaging, 535 E 70th St, New York, NY 10021 USA
[6] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA
基金
美国国家卫生研究院;
关键词
biomarkers; facioscapulohumeral muscular dystrophy; magnetic resonance spectroscopy; metabolite quantification; skeletal muscle; trimethylamine; IN-VIVO; SKELETAL-MUSCLE; LOWER LEG; BOYS; REPRODUCIBILITY; RELIABILITY; METABOLISM; EXERCISE; SPECTRA; MRI;
D O I
10.1002/mus.26048
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Facioscapulohumeral muscular dystrophy (FSHD) is a hereditary disorder that causes progressive muscle wasting. This study evaluates the use of proton magnetic resonance spectroscopy (H-1 MRS) as a biomarker of muscle strength and function in FSHD. Methods: Thirty-six individuals with FSHD and 15 healthy controls underwent multivoxel H-1 MRS of a cross-section of the mid-thigh. Concentrations of creatine, intramyocellular and extramyocellular lipids, and trimethylamine (TMA)-containing compounds in skeletal muscle were calculated. Metabolite concentrations for individuals with FSHD were compared with those of controls. The relationship between metabolite concentrations and muscle strength was also examined. Results: The TMA/creatine (Cr) ratio in individuals with FSHD was reduced compared with controls. The TMA/Cr ratio in the hamstrings also showed a moderate linear correlation with muscle strength. Discussion: H-1 MRS offers a potential method of detecting early muscle pathology in FSHD prior to the development of fat infiltration.
引用
收藏
页码:958 / 963
页数:6
相关论文
共 50 条
  • [21] Facioscapulohumeral muscular dystrophy
    Tawil R.
    Current Neurology and Neuroscience Reports, 2004, 4 (1) : 51 - 54
  • [22] Determining the role of sarcomeric proteins in facioscapulohumeral muscular dystrophy: a study protocol
    Lassche, Saskia
    Ottenheijm, Coen A. C.
    Voermans, Nicol C.
    Westeneng, Henk-Jan
    Janssen, Barbara H.
    van der Maarel, Silvere M.
    Hopman, Maria T.
    Padberg, George W.
    Stienen, Ger J. M.
    van Engelen, Baziel G. M.
    BMC NEUROLOGY, 2013, 13
  • [23] Muscle xenografts reproduce key molecular features of facioscapulohumeral muscular dystrophy
    Mueller, Amber L.
    O'Neill, Andrea
    Jones, Takako I.
    Llach, Anna
    Rojas, Luis Alejandro
    Sakellariou, Paraskevi
    Stadler, Guido
    Wright, Woodring E.
    Eyerman, David
    Jones, Peter L.
    Bloch, Robert J.
    EXPERIMENTAL NEUROLOGY, 2019, 320
  • [24] Resting metabolic rate in adults with facioscapulohumeral muscular dystrophy
    Vera, Kathryn
    McConville, Mary
    Kyba, Michael
    Keller-Ross, Manda
    APPLIED PHYSIOLOGY NUTRITION AND METABOLISM, 2021, 46 (09) : 1058 - 1064
  • [25] Leg Muscle Involvement in Facioscapulohumeral Muscular Dystrophy: Comparison between Facioscapulohumeral Muscular Dystrophy Types 1 and 2
    Mair, Dorothea
    Huegens-Penzel, Monika
    Kress, Wolfram
    Roth, Christian
    Ferbert, Andreas
    EUROPEAN NEUROLOGY, 2017, 77 (1-2) : 32 - 39
  • [26] Exercise Intolerance in Facioscapulohumeral Muscular Dystrophy
    Vera, Kathryn A.
    Mcconville, Mary
    Glazos, Aline
    Stokes, William
    Kyba, Michael
    Keller-Ross, Manda
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2022, 54 (06) : 887 - 895
  • [27] Muscle imaging in facioscapulohumeral muscular dystrophy research: A scoping review and expert recommendations
    Vincenten, Sanne C. C.
    Teeselink, Sjan
    Mul, Karlien
    Heskamp, Linda
    Kan, Hermien E.
    Heerschap, Arend
    Cameron, Donnie
    Tasca, Giorgio
    Leung, Doris G.
    Voermans, Nicol C.
    van Engelen, Baziel G. M.
    van Alfen, Nens
    NEUROMUSCULAR DISORDERS, 2025, 47
  • [28] ANT1 overexpression models: Some similarities with facioscapulohumeral muscular dystrophy
    Arbogast, Sandrine
    Kotzur, Heinrich
    Frank, Corinna
    Compagnone, Nathalie
    Sutra, Thibault
    Pillard, Fabien
    Pietri, Sylvia
    Hmada, Nisrine
    Moussa, Daouda Moustapha Abba
    Bride, Jamie
    Franconnet, Sarah
    Mercier, Jacques
    Crisol, Jean-Paul
    Dabavaulle, Marie-Christine
    Lauodj Cheniverse, Dalil
    REDOX BIOLOGY, 2022, 56
  • [29] Strength and functional correlates of reachable workspace in facioscapulohumeral muscular dystrophy
    Wang, Leo H.
    Hatch, Maya N.
    Mcdermott, Michael P.
    Martens, William B.
    Eichinger, Katy
    Lewis, Leann
    Walker, Michaela
    Leung, Doris G.
    Wagner, Kathryn R.
    Sacconi, Sabrina
    Mul, Karlien
    Shieh, Perry B.
    Elsheikh, Bakri
    Butterfield, Russell J.
    Johnson, Nicholas E.
    Sansone, Valeria
    Han, Jay J.
    Tawil, Rabi
    Statland, Jeffrey M.
    ReSolve Investigators FSHD CTRN
    NEUROMUSCULAR DISORDERS, 2025, 48
  • [30] Heart rate variability in facioscapulohumeral muscular dystrophy
    Della Marca, Giacomo
    Frusciante, Roberto
    Scatena, Michele
    Dittoni, Serena
    Testani, Elisa
    Vollono, Catello
    Losurdo, Anna
    Scarano, Emanuele
    Colicchio, Salvatore
    Farina, Benedetto
    Gnoni, Valentina
    Mazza, Salvatore
    Tonali, Pietro A.
    Ricci, Enzo
    FUNCTIONAL NEUROLOGY, 2010, 25 (04) : 211 - 216